The economic impact of viral hepatitis in the United States.
作者信息
Tolsma D D, Bryan J A
出版信息
Public Health Rep. 1976 Jul-Aug;91(4):349-53.
Abstract
摘要
相似文献
1
The economic impact of viral hepatitis in the United States.
Public Health Rep. 1976 Jul-Aug;91(4):349-53.
2
Advances in viral hepatitis. Report of the WHO Expert Committee on Viral Hepatitis.
World Health Organ Tech Rep Ser. 1977(602):1-62.
3
Acute viral hepatitis.
Aust Fam Physician. 1978 May;7(5):535-44.
4
[Etiology and epidemiology of viral hepatitis].
Rev Sanid Hig Publica (Madr). 1977 Nov-Dec;51(11-12):1311-35.
5
[Viral hepatitis A and B].
Wiad Lek. 1992 Jun;45(11-12):444-7.
6
Acute viral hepatitis: modern knowledge.
Pediatr Ann. 1977 May;6(5):299-310.
7
[The future of viral hepatitis vaccines].
Z Gesamte Hyg. 1985 Mar;31(3):134-7.
8
Recent advances in viral hepatitis types A and B.
Isr J Med Sci. 1979 Mar;15(3):231-9.
9
[Viral hepatitis types A and B].
Rev Gastroenterol Mex. 1982 Jul-Sep;47(3):125-37.
10
Hepatitis A.
Prog Liver Dis. 1986;8:299-310.
引用本文的文献
1
Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.
Pharmacoeconomics. 2009;27(5):379-89. doi: 10.2165/00019053-200927050-00003.
2
Assessment of immunoglobulin use for hepatitis A control in New Mexico.
Public Health Rep. 1982 Nov-Dec;97(6):516-20.
3
Viral hepatitis and the anaesthetist.
Can Anaesth Soc J. 1984 May;31(3 Pt 1):279-86. doi: 10.1007/BF03007889.
4
Vehicular carbon monoxide screening: identification in a cross-cultural setting of a substantial public health risk factor.
Am J Public Health. 1985 Jan;75(1):85-6. doi: 10.2105/ajph.75.1.85.
5
Benefit-cost analysis of active surveillance of primary care physicians for hepatitis A.
Am J Public Health. 1985 Feb;75(2):176-7. doi: 10.2105/ajph.75.2.176.
6
Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
J Epidemiol Community Health. 1992 Dec;46(6):587-94. doi: 10.1136/jech.46.6.587.
7
Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
Bull World Health Organ. 1992;70(6):757-67.
8
Syringe-transmitted hepatitis.
Br Med J. 1978 Oct 14;2(6144):1084. doi: 10.1136/bmj.2.6144.1084-b.
本文引用的文献
1
VIRAL HEPATITIS IN A GROUP OF BOSTON HOSPITALS. I. A RETROSPECTIVE STUDY OF 1675 PATIENTS.
N Engl J Med. 1965 Apr 1;272:657-61. doi: 10.1056/NEJM196504012721302.
2
RISK OF POST-TRANSFUSION VIRAL HEPATITIS.
N Engl J Med. 1964 Aug 13;271:337-42. doi: 10.1056/NEJM196408132710702.
3
NATIONAL SURVEY OF VENEREAL DISEASE TREATMENT.
JAMA. 1963 Oct 5;186:46-9. doi: 10.1001/jama.1963.63710010009013.
4
Infective hepatitis in Chrstchurch during 1969.
N Z Med J. 1970 Aug;72(459):98-104.
5
Risk of posttransfusion hepatitis in the United States. A prospective cooperative study.
JAMA. 1972 May 1;220(5):692-701. doi: 10.1001/jama.220.5.692.
6
The Holy Cross college football team hepatitis outbreak.
JAMA. 1972 Feb;219(6):706-8.
7
The changing epidemiology of viral hepatitis in the United States.
Am J Dis Child. 1972 Apr;123(4):350-4. doi: 10.1001/archpedi.1972.02110100082030.
8
Benefits due to immunization against measles.
Public Health Rep (1896). 1969 Aug;84(8):673-80.
9
Eight years of surveillance of patients hospitalized with hepatitis: interpretation of data in light of epidemic parenteral drug abuse and availability of testing for hepatitis-associated antigen.
J Infect Dis. 1972 Jul;126(1):87-91. doi: 10.1093/infdis/126.1.87.
10
Viral hepatitis: a group of epidemiologic entities.
Can Med Assoc J. 1972 Feb 26;106(Spec Issue):Suppl:427-34.
Zotero 插件